In a research of Twenty-nine people with preliminary breast cancer, the effectiveness of ptDNA (plasma Tumor DNA)/ddPCR for identifying PIK3CA mutations was established with 93.3% sensitivity and 100% specificity [27]. This evidence concerns the gene PIK3CA and breast cancer.